Role of apoptosis and autophagy in folic acid-induced cytotoxicity of human breast cancer cells in vitro
Corresponding Author
Munevver Baran
Department of Pharmaceutical Basic Science, Faculty of Pharmacy, Erciyes University, Kayseri, Turkey
Correspondence
Munevver Baran, Associated Professor, Department of Pharmaceutical Basic Science, Faculty of Pharmacy, Erciyes University, Kayseri, Turkey
Email: [email protected]; [email protected]
Search for more papers by this authorGozde Ozge Onder
Department of Histology and Embryology, Erciyes University, Faculty of Medicine, Kayseri, 38039 Turkey
Genome and Stem Cell Center (GENKOK), Erciyes University, Kayseri, Turkey
Search for more papers by this authorOzge Goktepe
Department of Histology and Embryology, Erciyes University, Faculty of Medicine, Kayseri, 38039 Turkey
Genome and Stem Cell Center (GENKOK), Erciyes University, Kayseri, Turkey
Search for more papers by this authorArzu Yay
Department of Histology and Embryology, Erciyes University, Faculty of Medicine, Kayseri, 38039 Turkey
Genome and Stem Cell Center (GENKOK), Erciyes University, Kayseri, Turkey
Search for more papers by this authorCorresponding Author
Munevver Baran
Department of Pharmaceutical Basic Science, Faculty of Pharmacy, Erciyes University, Kayseri, Turkey
Correspondence
Munevver Baran, Associated Professor, Department of Pharmaceutical Basic Science, Faculty of Pharmacy, Erciyes University, Kayseri, Turkey
Email: [email protected]; [email protected]
Search for more papers by this authorGozde Ozge Onder
Department of Histology and Embryology, Erciyes University, Faculty of Medicine, Kayseri, 38039 Turkey
Genome and Stem Cell Center (GENKOK), Erciyes University, Kayseri, Turkey
Search for more papers by this authorOzge Goktepe
Department of Histology and Embryology, Erciyes University, Faculty of Medicine, Kayseri, 38039 Turkey
Genome and Stem Cell Center (GENKOK), Erciyes University, Kayseri, Turkey
Search for more papers by this authorArzu Yay
Department of Histology and Embryology, Erciyes University, Faculty of Medicine, Kayseri, 38039 Turkey
Genome and Stem Cell Center (GENKOK), Erciyes University, Kayseri, Turkey
Search for more papers by this authorAbstract
Obstacles to the successful treatment of breast cancer patients with chemotherapeutic agents can be overcome with effective new strategies. It is still unclear how folic acid affects the onset and spread of breast cancer. The purpose of this study was to determine how folic acid affected the apoptotic and autophagic pathways of the breast cancer cell lines MCF-7 and MDA-MB-231. In the present study, folic acid was applied to MCF-7 and MDA-MB-231 breast cancer cell lines at different concentrations and for different durations. MTT analysis was used to investigate cytotoxic activity. All groups underwent the Tunel staining procedure to identify apoptosis and the immunofluorescence staining approach to identify the autophagic pathway. 24-hour folic acid values were accepted as the most appropriate cytotoxic dose. In MCF-7, cell cycle arrest was observed in the S phase and MDA-MB-231 G1/G0 phases. When apoptotic TUNEL staining was evaluated in both cell lines, folic acid significantly increased apoptosis. While a significant difference was observed between the groups in terms of Beclin 1 immunoreactivity in the MDA-MB-231 cell line, there was no significant difference in the MCF-7 cell line. In addition, statistical significance was not observed LC3 immunoreactivity in both cell lines. In the study, it was observed that folic acid induced autophagy at the initial stage in the MDA-MB-231 cell line but had no inductive effect in the MCF-7 cell line. In conclusion, our findings showed that folic acid has a potential cytotoxic and therapeutic effect on MCF-7 and MDA-MB-231 breast cancer cell lines.
CONFLICT OF INTEREST STATEMENT
The authors declare no potential conflicts of interest.
REFFERENCES
- 1Ghoncheh M, Pournamdar Z, Salehiniya H. Incidence and mortality and epidemiology of breast cancer in the world. Asian Pac J Cancer Prev. 2016; 17(sup3): 43-46.
- 2Rahnfeld L, Luciani P. Injectable lipid-based depot formulations: where do we stand? Pharmaceutics. 2020; 12(6): 567.
- 3Crider KS, Yang TP, Berry RJ, Bailey LB. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role. Adv Nutr. 2012; 3(1): 21-38.
- 4Gonen N, Assaraf YG. Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance. Drug Resist Updat. 2012; 15(4): 183-210.
- 5Kabilova TO, Shmendel EV, Gladkikh DV, et al. Targeted delivery of nucleic acids into xenograft tumors mediated by novel folate-equipped liposomes. Eur J Pharm Biopharm. 2018; 123: 59-70.
- 6Larsson SC, Giovannucci E, Wolk A. Folate and risk of breast cancer: a meta-analysis. J Natl Cancer Inst. 2007; 99(1): 64-76.
- 7Kim YI. Folate and colorectal cancer: An evidence-based critical review. Mol Nutr Food Res. 2007; 51(3): 267-292.
- 8Assaraf YG, Leamon CP, Reddy JA. The folate receptor as a rational therapeutic target for personalized cancer treatment. Drug Resist Updat. 2014; 17(4-6): 89-95.
- 9Vollset SE, Clarke R, Lewington S, et al. Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50 000 individuals. Lancet. 2013; 381(9871): 1029-1036.
- 10Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004; 116(2): 205-219.
- 11Zhang HW, Hu JJ, Fu RQ, et al. Flavonoids inhibit cell proliferation and induce apoptosis and autophagy through downregulation of PI3Kγ mediated PI3K/AKT/mTOR/p70S6K/ULK signaling pathway in human breast cancer cells. Sci Rep. 2018; 8(1): 1-13.
- 12Goldsmith J, Levine B, Debnath J. Autophagy and cancer metabolism. Methods Enzymol. 2014; 542: 25-57.
- 13Mizushima N. The exponential growth of autophagy-related research: from the humble yeast to the Nobel Prize. FEBS Lett. 2017; 591: 681-689.
- 14Moussa C, Ross N, Jolette P, MacFarlane AJ. Altered folate metabolism modifies cell proliferation and progesterone secretion in human placental choriocarcinoma JEG-3 cells. Br J Nutr. 2015; 114(6): 844-852.
- 15Lamm N, Maoz K, Bester AC, et al. Folate levels modulate oncogene-induced replication stress and tumorigenicity. EMBO Mol Med. 2015; 7(9): 1138-1152.
- 16Hwang SY, Kang YJ, Sung B, et al. Folic acid is necessary for proliferation and differentiation of C2C12 myoblasts. J Cell Physiol. 2018; 233(2): 736-747.
- 17Bitgen N, Baran M, Önder GÖ, Suna PA, Gürbüz P, Yay A. Effect of Melissa officinalis L. on human breast cancer cell line via apoptosis and autophagy. Cukurova Med J. 2022; 47(2): 765-775.
- 18Baran M, Ozturk F, Canoz O, Onder GO, Yay A. The effects of apoptosis and apelin on lymph node metastasis in invasive breast carcinomas. Clin Exp Med. 2020; 20: 507-514.
- 19Yeoh CY, Rosandy AR, Khalid RM, Cheah YK. Barrientosiimonas humi ethyl acetate extract exerts cytotoxicity against MCF-7 and MDA-MB-231 cells via induction of apoptosis and cell cycle arrest. Asian Pac J Trop Biomed. 2022; 12(2): 87.
- 20Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65(2): 87-108.
- 21Naushad SM, Divya C, Janaki Ramaiah M, Hussain T, Alrokayan SA, Kutala VK. Population-level diversity in the association of genetic polymorphisms of one-carbon metabolism with breast cancer risk. J Community Genet. 2016; 7: 279-290.
- 22Cancarini I, Krogh V, Agnoli C, et al. Micronutrients involved in one-carbon metabolism and risk of breast cancer subtypes. PLoS ONE. 2015; 10(9):e0138318.
- 23Maruti SS, Ulrich CM, White E. Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. Am J Clin Nutr. 2009; 89(2): 624-633.
- 24Yegnasubramanian S, Haffner MC, Zhang Y, et al. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. Cancer Res. 2008; 68(21): 8954-8967.
- 25Huang Y, Nayak S, Jankowitz R, Davidson NE, Oesterreich S. Epigenetics in breast cancer: what's new? Breast Cancer Res. 2011; 13(6): 1-11.
- 26Cuenca-Micó O, Aceves C. Micronutrients and Breast Cancer Progression: A Systematic Review. Nutrients. 2020; 12(12): 3613.
- 27Mathers JC. Folate intake and bowel cancer risk. Genes Nutr. 2009; 4(3): 173-178.
- 28 World Cancer Research Fund; American Institute for Cancer Research. Diet, nutrition, physical activity and breast cancer. Continuous Update Project Expert Report. 2018.
- 29Frigerio B, Bizzoni C, Jansen G, et al. Folate receptors and transporters: biological role and diagnostic/therapeutic targets in cancer and other diseases. J Exp Clin Cancer Res. 2019; 38(1): 125.
- 30Díaz-García D, Montalbán-Hernández K, Mena-Palomo I, et al. Role of folic acid in the therapeutic action of nanostructured porous silica functionalized with organotin (IV) compounds against different cancer cell lines. Pharmaceutics. 2020; 12(6): 512.
- 31Srinivasarao M, Galliford CV, Low PS. Principles in the design of ligandtargeted cancer therapeutics and imaging agents. Nat Rev Drug Discov. 2015; 14: 203-219.
- 32Li Q, van der Wijst MG, Kazemier HG, Rots MG, Roelfes G. Efficient nuclear DNA cleavage in human cancer cells by synthetic bleomycin mimics. ACS Chem Biol. 2014; 9: 1044-1051.
- 33Hansen MF, Jensen SØ, Füchtbauer EM, Martensen PM. High folic acid diet enhances tumour growth in PyMT-induced breast cancer. Br J Cancer. 2017; 116(6): 752-761.
- 34Oleinik NV, Helke KL, Kistner-Griffin E, Krupenko NI, Krupenko SA. Rho GTPases RhoA and Rac1 mediate effects of dietary folate on metastatic potential of A549 cancer cells through the control of cofilin phosphorylation. J Biol Chem. 2014; 289(38): 26383-26394.
- 35Tomaszewski JJ, Cummings JL, Parwani AV, et al. Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate. Prostate. 2011; 71(12): 1287-1293.
- 36Kuo CS, Lin CY, Wu MY, Lu CL, Huang RF. Relationship between folate status and tumour progression in patients with hepatocellular carcinoma. Br J Nutr. 2008; 100(3): 596-602.
- 37Kim KC, Friso S, Choi SW. DNA methylation, an epigenetic mechanism connecting folate to healthy embryonic development and aging. J Nutr Biochem. 2009; 20(12): 917-926.
- 38Vermeulen K, Berneman ZN, Van Bockstaele DR. Cell cycle and apoptosis. Cell Prolif. 2003; 36(3): 165-175.
- 39Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007; 35(4): 495-516.
- 40Deghan Manshadi S, Ishiguro L, Sohn KJ, et al. Folic acid supplementation promotes mammary tumor progression in a rat model. PLoS ONE. 2014; 9(1):e84635.
- 41Kayani Z, Bordbar AK, Firuzi O. Novel folic acid-conjugated doxorubicin loaded β-lactoglobulin nanoparticles induce apoptosis in breast cancer cells. Biomed Pharmacother. 2018; 107: 945-956.
- 42Chen J, Zhu Y, Zhang W, et al. Delphinidin induced protective autophagy via mTOR pathway suppression and AMPK pathway activation in HER-2 positive breast cancer cells. BMC Cancer. 2018; 18(1): 342.
- 43Ozpolat B, Benbrook DM. Targeting autophagy in cancer management–strategies and developments. Cancer Manag Res. 2015; 7: 291-299.
- 44Zhou L, Wang M, Gu C, et al. Expression of pAkt is associated with a poor prognosis in Chinese women with invasive ductal breast cancer. Oncol Lett. 2018; 15(4): 4859-4866.
- 45Fimia GM, Corazzari M, Antonioli M, Piacentini M. Ambra1 at the crossroad between autophagy and cell death. Oncogene. 2013; 32(28): 3311-3318.
- 46Mohammadi A, Omrani L, Omrani LR, et al. Protective effect of folic acid on cyclosporine-induced bone loss in rats. Transpl Int. 2012; 25(1): 127-133.
- 47Harlan De Crescenzo A, Panoutsopoulos AA, Tat L, et al. Deficient or Excess Folic Acid Supply During Pregnancy Alter Cortical Neurodevelopment in Mouse Offspring. Cereb Cortex. 2021; 31(1): 635-649.
- 48Vega-Rubín-de-Celis S. The role of Beclin 1-dependent autophagy in cancer. Biology. 2019; 9(1): 4.
- 49Hu Z, Zhong Z, Huang S, et al. Decreased expression of Beclin-1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma. Mol Med Rep. 2016; 14(2): 1567-1573.
- 50Zhao H, Yang M, Zhao J, Wang J, Zhang Y, Zhang Q. High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancer. Med Oncol. 2013; 30: 475.
- 51Lefort S, Joffre C, Kieffer Y, et al. Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers. Autophagy. 2014; 10(12): 2122-2142.
- 52Miller JW, Ulrich CM. Folic acid and cancer—where are we today? Lancet. 2013; 381(9871): 974-976.
- 53Tio M, Andrici J, Eslick GD. Folate intake and the risk of breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2014; 145: 513-524.
- 54Chen P, Li C, Li X, Li J, Chu R, Wang H. Higher dietary folate intake reduces the breast cancer risk: a systematic review and meta-analysis. Br J Cancer. 2014; 110: 2327-2338.